Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
Depth of invasion
Epithelial–mesenchymal transition
Microenvironment
Tongue cancer
Tumor budding
Tumor–stroma ratio
Journal
International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
15
04
2022
accepted:
24
09
2022
pubmed:
6
10
2022
medline:
30
11
2022
entrez:
5
10
2022
Statut:
ppublish
Résumé
cT1/2 oral tongue squamous cell carcinoma (OTSCC) often metastasizes to cervical lymph nodes. However, predicting neck lymph-node metastasis (NLM) remains challenging. Pathomorphological evaluation of tumor budding grade (TBG) and tumor-stroma ratio (TSR) reportedly can predict lymph-node metastases. Hence, this study aimed to evaluate TBG and TSR in OTSCC and investigate their relationship to occult NLM and cancer relapse. Clinicopathological data of patients with cT1/2N0 OTSCC treated at the University of Tokyo Hospital between 2007 and 2017 were collected. TBG and TSR were evaluated using hematoxylin-eosin staining and cytokeratin AE1/AE3 immunostaining. Out of 70 patients, 16 underwent elective neck dissection in addition to primary-tumor resection, whereas 54 did not. During follow-up, NLM was found in 35 patients. NLM correlated with the pathological depth of invasion (pDOI) (p < 0.001), TBG (p = 0.008), and TSR (p < 0.001) in univariate analysis and pDOI (p = 0.01) and TSR (p = 0.02) in multivariate analysis. The 5-year recurrence-free survival rate (RFS) was 78% for patients with a pDOI ≤ 5 mm and stroma-poor tumors and 33% for patients with a pDOI > 5 mm and stroma-rich tumors. Patients with a pDOI > 5 mm and stroma-rich tumors have a high risk for cancer relapse. TSR and pDOI may be promising NLM predictors in cT1/2N0 OTSCC.
Sections du résumé
BACKGROUND
BACKGROUND
cT1/2 oral tongue squamous cell carcinoma (OTSCC) often metastasizes to cervical lymph nodes. However, predicting neck lymph-node metastasis (NLM) remains challenging. Pathomorphological evaluation of tumor budding grade (TBG) and tumor-stroma ratio (TSR) reportedly can predict lymph-node metastases. Hence, this study aimed to evaluate TBG and TSR in OTSCC and investigate their relationship to occult NLM and cancer relapse.
METHODS
METHODS
Clinicopathological data of patients with cT1/2N0 OTSCC treated at the University of Tokyo Hospital between 2007 and 2017 were collected. TBG and TSR were evaluated using hematoxylin-eosin staining and cytokeratin AE1/AE3 immunostaining.
RESULTS
RESULTS
Out of 70 patients, 16 underwent elective neck dissection in addition to primary-tumor resection, whereas 54 did not. During follow-up, NLM was found in 35 patients. NLM correlated with the pathological depth of invasion (pDOI) (p < 0.001), TBG (p = 0.008), and TSR (p < 0.001) in univariate analysis and pDOI (p = 0.01) and TSR (p = 0.02) in multivariate analysis. The 5-year recurrence-free survival rate (RFS) was 78% for patients with a pDOI ≤ 5 mm and stroma-poor tumors and 33% for patients with a pDOI > 5 mm and stroma-rich tumors.
CONCLUSION
CONCLUSIONS
Patients with a pDOI > 5 mm and stroma-rich tumors have a high risk for cancer relapse. TSR and pDOI may be promising NLM predictors in cT1/2N0 OTSCC.
Identifiants
pubmed: 36197545
doi: 10.1007/s10147-022-02249-y
pii: 10.1007/s10147-022-02249-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1818-1827Subventions
Organisme : Japan Society for the Promotion of Science
ID : KAKENHI Grant-in-Aid for Young Scientists (Grant No. 20K18272)
Informations de copyright
© 2022. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.
Références
Ebrahimi A, Ashford BG, Clark JR (2012) Improved survival with elective neck dissection in thick early-stage oral squamous cell carcinoma. Head Neck 34:709–716
doi: 10.1002/hed.21809
pubmed: 21739519
Ebrahimi A, Gil Z, Amit M et al (2014) Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. International Consortium for Outcome Research (ICOR) in head and neck cancer. JAMA Otolaryngol Head Neck Surg 140:1138–1148
doi: 10.1001/jamaoto.2014.1548
pubmed: 25075712
Asakage T, Yokose T, Mukai K et al (1998) Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer 82:1443–1448
doi: 10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A
pubmed: 9554518
Huang SH, Hwang D, Lockwood G et al (2009) Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 115:1489–1497
doi: 10.1002/cncr.24161
pubmed: 19197973
D’Cruz AK, Vaish R, Kapre N et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529
doi: 10.1056/NEJMoa1506007
pubmed: 26027881
NCCN (2022) Clinical Practice Guidelines in Oncology Head and Neck Cancers Version 1. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf . Accessed Dec 2021
Lugli A, Zlobec I, Berger MD et al (2021) Tumour budding in solid cancers. Nat Rev Clin Oncol 18:101–115
doi: 10.1038/s41571-020-0422-y
pubmed: 32901132
Turley SJ, Cremasco V, Astarita JL (2015) Immunological hallmarks of stromal cells in the tumour microenvironment. Nat Rev Immunol 15:669–682
doi: 10.1038/nri3902
pubmed: 26471778
Ebihara Y, Yoshida S, Nakahira M et al (2019) Importance of tumor budding grade as independent prognostic factor for early tongue squamous cell carcinoma. Head Neck 41:1809–1815
doi: 10.1002/hed.25614
pubmed: 30633412
Watanabe T, Muro K, Ajioka Y et al (2018) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol 23:1–34
doi: 10.1007/s10147-017-1101-6
pubmed: 28349281
Wang C, Huang H, Huang Z et al (2011) Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 40:545–551
doi: 10.1111/j.1600-0714.2011.01041.x
pubmed: 21481005
pmcid: 3135705
Attramadal CG, Kumar S, Boysen ME et al (2015) Tumor budding, EMT and cancer stem cells in T1–2/N0 oral squamous cell carcinomas. Anticancer Res 35:6111–6120
pubmed: 26504037
Ueno H, Kanemitsu Y, Sekine S et al (2017) Desmoplastic pattern at the tumor front defines poor-prognosis subtypes of colorectal cancer. Am J Surg Pathol 41:1506–1512
doi: 10.1097/PAS.0000000000000946
pubmed: 28877064
Ueno H, Kanemitsu Y, Sekine S et al (2019) A multicenter study of the prognostic value of desmoplastic reaction categorization in stage II colorectal cancer. Am J Surg Pathol 43:1015–1022
doi: 10.1097/PAS.0000000000001272
pubmed: 31094924
Almangush A, Heikkinen I, Bakhti N et al (2018) Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Histopathology 72:1128–1135
doi: 10.1111/his.13481
pubmed: 29427291
Van Pelt GW, Kjaer-Frifeldt S, van Krieken J et al (2018) Scoring the tumor–stroma ratio in colon cancer: procedure and recommendations. Virchows Arch 473:405–412
doi: 10.1007/s00428-018-2408-z
pubmed: 30030621
pmcid: 6182321
Mascitti M, Zhurakivska K, Togni L et al (2020) Addition of the tumour–stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma. Histopathology 77:810–822
doi: 10.1111/his.14202
pubmed: 32633006
Omura G, Ando M, Saito Y et al (2016) Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer. Head Neck 38:1164–1169
doi: 10.1002/hed.24176
pubmed: 27061113
Miyazaki T, Kato H, Nakajima M et al (2003) FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 89:140–145
doi: 10.1038/sj.bjc.6601050
pubmed: 12838315
pmcid: 2394235
Fu W, Hall JE, Schaller MD (2012) Focal adhesion kinase-regulated signaling events in human cancer. Biomol Concepts 3:225–240
doi: 10.1515/bmc-2011-0049
pubmed: 25436535
McLean GW, Carragher NO, Avizienyte E et al (2005) The role of focal-adhesion kinase in cancer–a new therapeutic opportunity. Nat Rev Cancer 5:505–515
doi: 10.1038/nrc1647
pubmed: 16069815
Hasegawa Y, Tsukahara K, Yoshimoto S et al (2021) Neck dissections based on sentinel lymph node navigation versus elective neck dissections in early oral cancers: a randomized, multicenter, and noninferiority trial. J Clin Oncol 39:2025–2036
doi: 10.1200/JCO.20.03637
pubmed: 33877855
Dourado MR, Miwa KYM, Hamada GB et al (2020) Prognostication for oral squamous cell carcinoma patients based on the tumour–stroma ratio and tumour budding. Histopathology 76:906–918
doi: 10.1111/his.14070
pubmed: 31984527
Chen C, Zimmermann M, Tinhofer I et al (2013) Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer Lett 338:47–56
doi: 10.1016/j.canlet.2012.06.013
pubmed: 22771535
Smith A, Teknos TN, Pan Q (2013) Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol 49:287–292
doi: 10.1016/j.oraloncology.2012.10.009
pubmed: 23182398
Wang M, Zhao J, Zhang L et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8:761–773
doi: 10.7150/jca.17648
pubmed: 28382138
pmcid: 5381164
D’Arcangelo E, Wu NC, Cadavid JL et al (2020) The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome. Br J Cancer 122:931–942
doi: 10.1038/s41416-019-0705-1
pubmed: 31992854
pmcid: 7109057
Li YY, Tao YW, Gao S et al (2018) Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. E Bio Medicine 36:209–220
Dourado MR, Korvala J, Astrom P et al (2019) Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma. J Extracell Vesicles 28:1578525
doi: 10.1080/20013078.2019.1578525
Dourado MR, Guerra ENS, Salo T et al (2018) Prognostic value of the immunohistochemical detection of cancer-associated fibroblasts in oral cancer: a systematic review and meta-analysis. J Oral Pathol Med 47:443–453
doi: 10.1111/jop.12623
pubmed: 28782893
Bagordakis E, Sawazaki-Calone I, Macedo CC et al (2016) Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures. Tumour Biol 37:9045–9057
doi: 10.1007/s13277-015-4629-y
pubmed: 26762409
Mellone M, Hanley CJ, Thirdborough S et al (2016) Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis. Aging 9:114–132
doi: 10.18632/aging.101127
pubmed: 27992856
pmcid: 5310659
Gabarra-Niecko V, Schaller MD, Dunty JM (2003) FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 22:359–374
doi: 10.1023/A:1023725029589
pubmed: 12884911
Zhao J, Guan JL (2009) Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28:35–49
doi: 10.1007/s10555-008-9165-4
pubmed: 19169797
Sulzmaier FJ, Jean C, Schlaepfer DD (2014) FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer 14:598–610
doi: 10.1038/nrc3792
pubmed: 25098269
pmcid: 4365862